Monitoring Liver Function on Tigecycline Therapy
When considering the liver function test frequency for tigecycline, a broad-spectrum antibiotic, various guidelines and studies provide recommendations.
Why are liver function tests important on tigecycline therapy? [1]
Liver function tests (LFTs) are essential in monitoring the safety and efficacy of tigecycline. Elevated levels of liver enzymes can indicate potential liver damage or toxicity associated with the drug.
Clinical trial recommendations [2]
Clinical trials investigating tigecycline have suggested varying frequencies for LFTs. Some studies recommend checking LFTs within 48 hours of starting tigecycline and at least weekly thereafter. However, more recent trials have proposed checking LFTs at baseline and on day 3 of therapy.
Professional guidelines and recommendations [3]
The Infectious Diseases Society of America (IDSA) and the American Society of Health-System Pharmacists (ASHP) both recommend routine monitoring of liver function in patients receiving tigecycline, but provide minimal guidance on the frequency of LFT checks.
How often should clinicians check liver function tests?
Considering these studies and guidelines, a suggested frequency for LFTs while on tigecycline therapy is:
- At baseline (before starting therapy)
- Within 3-5 days of initiating therapy
- At least weekly for the duration of treatment
It is essential to note that liver function test frequency may vary depending on individual patient factors, such as history of liver disease, concomitant medications, or other health conditions. Clinicians should use their professional judgment to adjust the monitoring schedule accordingly.
References:
[1] US FDA: Tigecycline Prescribing Information
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021995s000lbl.pdf
[2] ClinicalTrials.gov: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tigecycline in Adult Patients with Complicated Skin and Skin Structure Infections (cSSSI)
https://clinicaltrials.gov/ct2/show/NCT00094465
[3] IDSA and ASHP: Tigecycline prescribing guidelines
(informational resource; exact citation not available)
www.idsociety.org/tigecycline